ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

New Tool Found To Cut DNA At Any Position

April 4, 1986

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003